Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
about
Fluoroquinolone resistance in Neisseria gonorrhoeaePreparing for an era of untreatable gonorrheaSulfamethoxazole-trimethoprim synergism for Neisseria gonorrhoeae.Treating gonococcal infections resistant to penicillin in Bangkok: comparison of cefuroxime and spectinomycin.Pharmacological and in vitro evaluation of cyclacillin: assessment as potential single-dose therapy for treatment of Neisseria gonorrhoeae infectionSerum and subcutaneous chamber fluid dynamics of penicillins after single large parenteral dosesThe use of cephalosporins for gonorrhea: an update on the rising problem of resistance.Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin.Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infectionProposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.Therapeutic trial and pharmacokinetics of sulbactam for uncomplicated gonorrhea in menTime-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeaeCephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.Current and future treatment options for gonorrhoea.Evolving gonococcal antimicrobial resistance: research priorities and implications for management.Penicillin sensitivities of gonoccocci, in 1977-80 from a peripheral health district, and their clinical correlation.Cefodizime in serum and skin blister fluid after single intravenous and intramuscular doses in healthy volunteers.Antimicrobial breakpoint estimation accounting for variability in pharmacokinetics.[Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].
P2860
Q24647899-8DB698E9-365D-4346-9696-72B0C11B15ACQ27002771-E0026FB4-2EE2-45E7-9CC6-017A4A9437F7Q30451407-FC874DDF-77C3-46ED-A162-9536A577A225Q33582915-1DEC8762-EA71-4A6C-AC57-AF80BD5B650EQ33722648-7D5804A9-3667-453C-9A83-94BD3915B6A8Q33723968-FCD46466-E1F9-422C-8F52-535DB2F87E62Q33836057-020C9A83-FABD-407A-A5A9-C5FC09FD08FCQ33974655-99B86923-6623-4C89-AA47-1E2A4DB748A1Q34141627-B568E674-52ED-4A91-93CB-F2810DEC2138Q35120200-7C968BDC-F0B3-41DA-8E55-2E771EDB16E0Q35640481-2092CA58-92D1-4266-8C8E-1F29772C1DB9Q36136318-11B30FD2-1DF0-4485-8255-C52787155D5AQ37778640-BAE10EC7-2B3A-4E88-919A-245185B78F06Q37905141-6FCAC81B-6582-431C-9C3E-8391DB12A211Q38150832-B753F301-8721-4AC9-8715-2A1E92586433Q38163515-DA93CD0D-3F1F-4F0D-AE6A-120C678E1B0DQ39112154-CB10BDAE-19EA-4105-B331-3D2AC3935624Q39829105-368D25F5-3A4A-440D-8379-9ABBE98D78C8Q42040822-B677CCDB-9578-496C-B4E7-34BB43D12F6EQ44275701-47097568-6912-435B-A43D-36B3B6D54221
P2860
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@ast
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@en
type
label
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@ast
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@en
prefLabel
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@ast
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@en
P2093
P2860
P356
P1476
Pharmacokinetic determinants of penicillin cure of gonococcal urethritis.
@en
P2093
Martin JE Jr
Reynolds GH
Schroeter AL
P2860
P304
P356
10.1128/AAC.15.4.587
P407
P577
1979-04-01T00:00:00Z